Using data science to forecast clinical trial outcomes
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
By
The COVID-19 pandemic damages the U.S. and the world economy and puts policymakers in an unfamiliar dilemma. Non-pharmaceutical interventions (NPIs) such as social distancing slow the spread of [...]
By
AI is a tool to get things done. To use it properly and generate value, organizations need the right capabilities — including a good understanding of data.
By
In a new book, MIT roboticist Daniela Rus looks at the powers and limitations of robots and how humans can work with them to unlock new capabilities.
By
The MIT Sloan School of Management announces a major gift from alumnus Bennett (Ben) W. Golub to support the MIT Center for Finance and Policy.
By
Machine learning is a powerful form of artificial intelligence that is affecting every industry. Here’s what you need to know about its potential and limitations and how it’s being used.
By
Companies make common data science mistakes. Here’s an expert’s guide to what they are and how to avoid them.
By
In an article in The Hill, Bob Pozen explores how the recently enacted Cares Act has tax provisions that favor wealthy investors and large companies. There is proposed legislation now in Congress to [...]
By
In a new book about the history of Kendall Square from the MIT Press, author Robert Buderi chronicles the area's biggest successes in innovation.